Literature DB >> 929113

The parathyroid glands in experimentally induced hypergastrinemia in the rat.

L Grimelius, H Johansson, G Lundqvist, A Olazabal, J H Polak, G E Pearse.   

Abstract

The morphology of the parathyroids in rats with hypergastrinemia, induced by antral exclusion, was compared with that of glands from untreated rats and animals from which the main source of gastrin- 17 was excluded (antral resection). Fourteen weeks after induction of hypergastrinemia the volume of the parathyroids was significantly increased owing to hyperplasia of the parenchymal cells. Removal of the antral gastrin-producing capacity of the same duration was not accompanied by any significant changes in the parathyroids. These findings suggest that hypergastrinemia could be a stimulus for the development of hyperplasia of the parathyroids, and that it may be an etiological factor in the production of hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 929113     DOI: 10.3109/00365527709181713

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

1.  The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  Laura E Targownik; William D Leslie; K Shawn Davison; David Goltzman; Sophie A Jamal; Nancy Kreiger; Robert G Josse; Stephanie M Kaiser; Christopher S Kovacs; Jerilynn C Prior; Wei Zhou
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

2.  Hip fracture risk in patients with a diagnosis of pernicious anemia.

Authors:  Nathan A Merriman; Mary E Putt; David C Metz; Yu-Xiao Yang
Journal:  Gastroenterology       Date:  2009-12-21       Impact factor: 22.682

Review 3.  Chronic proton pump inihibitor therapy and calcium metabolism.

Authors:  Yu-Xiao Yang
Journal:  Curr Gastroenterol Rep       Date:  2012-12

4.  Estimation of parenchymal cell content of human parathyroid glands using the image analyzing computer technique.

Authors:  L Grimelius; G Akerström; H Johansson; H Lundqvist
Journal:  Am J Pathol       Date:  1978-12       Impact factor: 4.307

5.  Is there any association of osteoporosis with proton pump inhibitor use? (Gastroenterology 2010;138:896-904).

Authors:  Hye-Kyung Jung
Journal:  J Neurogastroenterol Motil       Date:  2010-07-26       Impact factor: 4.924

Review 6.  Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: A review.

Authors:  Federica Cavalcoli; Alessandra Zilli; Dario Conte; Sara Massironi
Journal:  World J Gastroenterol       Date:  2017-01-28       Impact factor: 5.742

Review 7.  Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved.

Authors:  Benjamin Ka Seng Thong; Soelaiman Ima-Nirwana; Kok-Yong Chin
Journal:  Int J Environ Res Public Health       Date:  2019-05-05       Impact factor: 3.390

Review 8.  Proton Pump Inhibitors and Fractures in Adults: A Critical Appraisal and Review of the Literature.

Authors:  Silvia Irina Briganti; Anda Mihaela Naciu; Gaia Tabacco; Roberto Cesareo; Nicola Napoli; Pierpaolo Trimboli; Marco Castellana; Silvia Manfrini; Andrea Palermo
Journal:  Int J Endocrinol       Date:  2021-01-15       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.